Idenix Pharmaceuticals (IDIX)

[keitern]

Thanks to all for the debate here re. Tyzeka uptake. Since there seems to be at least 2 equations in play here, namely the percentage of the HBV market Tyzeka will capture over time and the increase in the incidence of HBV diagnosis, it would be very helpful to have the LOW END end resolution of these as to the positive cash flow for IDIX going forward. 2007, 8, 9, 10 etc. Probably asking too much, but thanks in advance to anyone who would give it a shot.